RANKL blocking drugs, new approach to errosive arthritis

[Mike Bartolatz]

http://www.pubmedcentral.nih.gov/articl ... id=1924517

a new biological drug in Phase II trials is looking at a novel approach to stopping bone loss in Rheumatoid arthritis and other forms of errosive arthritis.

Wish all the best,
Mike

[Mike Bartolatz]

http://www.hopkins-arthritis.org/physic ... -2120.html

interesting commetary at the end of this article

mike